🇺🇸 FDA
Pipeline program

Intranasal corticosteroids (INCS) combined with oral antihistamines (OAH) used for treatment

2025101109

Approved small_molecule active

Quick answer

Intranasal corticosteroids (INCS) combined with oral antihistamines (OAH) used for treatment for Allergic Rhinitis is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Allergic Rhinitis
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials